asthma management

Weight-loss surgery may reduce asthma-related ED visitsStudy suggests safe, effective, non-surgical approaches to achieve major weight loss ideal for obese individuals with asthma.
Women hospitalized more for asthma than men
Women hospitalized more for asthma than menA new study notes that while men and women have similar risk factors for asthma flare-ups, the latter are hospitalized at a greater rate.
FDA panel backs approval of GSK's mepolizumab for severe asthmaThe FDA’s Pulmonary-Allergy Drugs Advisory Committee recently recommended approval of GlaxoSmithKline Plc's drug mepolizumab (Nucala) for severe asthma patients 18 and older.
Study: Weight loss key to manage asthma in obese adults
Study: Weight loss key to manage asthma in obese adultsIn obese adults with asthma, losing weight can help reduce asthma severity, according to the results of a Canadian study.
Treating allergic rhinitis through better patient managementThe Asthma and Allergy Foundation of America estimates that 50 million Americans suffer from allergic rhinitis, which includes hay fever and seasonal or perennial indoor/outdoor nasal allergies. These conditions are thought to affect up to 30% of adults and 40% of children, according to reports from the American College of Asthma Allergy & Immunology. This represents a marked increase over past decades; in the 1940s, hay fever was estimated to affect only 1% of the U. S. population.
Tiotropium improved asthma symptoms in phase 3 trialsNew data from Phase III trials showed that the addition of tiotropium Respimat in adult patients with mild, moderate and severe asthma who continue to experience symptoms despite the use of maintenance therapies improved lung function. Boehringer Ingelheim recently presented the new data on investigational tiotropium delivered via Respimat® inhaler at the 2015 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Houston, Texas.
  • 1
  • 2